Bcel stock forecast.

Coterra Energy Inc () Stock Market info Recommendations: Buy or sell Coterra Energy stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Coterra Energy share forecasts, stock quote and buy / sell signals below.According to present data Coterra Energy's CTRA shares and potentially its market environment have …Find real-time NU - Nu Holdings Ltd stock quotes, company profile, news and forecasts from CNN Business.Atreca (BCEL) Insider Trading Activity 2023. All the trading advice you’ve ever received boils down to this (Ad) How major US stock indexes fared Friday, 12/1/2023. US targets oil and natural gas industry's role in global warming with new rule on methane emissions. S&P 500 4,594.63. DOW 36,245.50.Last reporting date. November 13, 2023. EPS forecast (this quarter) -$68.00. Annual revenue (last year) $1.1B. Annual profit (last year) -$415.6M. Net profit margin.Next reporting date. December 19, 2023. EPS forecast (this quarter) -$0.08. Annual revenue (last year) $130.5M. Annual profit (last year) -$142.7M. Net profit margin.

BCEL Overview Stock Screener Earnings Calendar Sectors Nasdaq | BCEL U.S.: Nasdaq Atreca Inc. Cl A Watch Set a price target alert After Hours Last Updated: Nov 17, 2023 6:22 p.m. EST Delayed...Nov 6, 2023 · BCEL Stock Predictions, Articles, and Atreca Inc Cl A News From InvestorPlace From the Web 3 Penny Stocks to Catapult You Into the Millionaires’ Club By Omor Ibne Ehsan Jul 13, 2023 ...

Find the latest Atreca, Inc. (BCEL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company’s product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-002 and VRDN ...Next reporting date. December 19, 2023. EPS forecast (this quarter) -$0.08. Annual revenue (last year) $130.5M. Annual profit (last year) -$142.7M. Net profit margin. The rating of the stock has changed to hold according to some analysts. It's at an all time low, buy folks thanks me later. Recently BCEL has reached an all time low and a data suggests that is will rise back up. According to Fintel.IO Blackrock has bought a staggering 350k shares. The rating of the stock has changed to hold according to some ... The current Atreca [ BCEL] share price is $0.21. The Score for BCEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. BCEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.

Nov 10, 2023 · The latest Atreca stock prices, stock quotes, news, and BCEL history to help you invest and trade smarter. ... The 11 analysts offering price forecasts for Atreca have a median target of 11.77 ...

Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Dec 1, 2023 · 12 analysts have issued twelve-month price objectives for CymaBay Therapeutics' stock. Their CBAY share price targets range from $12.00 to $34.00. On average, they anticipate the company's stock price to reach $22.27 in the next year. This suggests a possible upside of 24.4% from the stock's current price. View analysts price targets for CBAY ... $191.45 +1.76 +0.93% Find the latest analyst research for Atreca, Inc. Class A Common Stock (BCEL) at Nasdaq.com.Nov 30, 2023 · The Atreca Inc. stock price gained 5.36% on the last trading day (Friday, 17th Nov 2023), rising from $0.209 to $0.220. During the last trading day the stock fluctuated 9.33% from a day low at $0.210 to a day high of $0.230. The price has been going up and down for this period, and there has been a -16.59% loss for the last 2 weeks. A list of analyst ratings for Atreca (BCEL) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. ... Forecast; Analyst Ratings; BCEL's stock price has decreased by -82.11% in the past year and price targets may not have had time to catch up.

According to . 3 Wall Street analysts that have issued a 1 year BCEL price target, the average BCEL price target is $9.00, with the highest BCEL stock price forecast at $25.00 and the lowest BCEL stock price forecast at $1.00. Find real-time BCE - BCE Inc stock quotes, company profile, news and forecasts from CNN Business.Zacks Equity Research. April 6, 2023 at 9:55 AM · 3 min read. Shares of Atreca, Inc. (BCEL) have been struggling lately and have lost 20% over the past week. However, a hammer chart pattern was ...Explore Atreca, Inc. (BCEL) earnings date, Atreca, Inc. stock earnings history, EPS, estimated EPS, earnings-related price changes, and more.2010. 90. John Orwin. https://www.atreca.com. Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified ...Dec 1, 2023 · Their VKTX share price targets range from $19.00 to $37.00. On average, they predict the company's stock price to reach $30.25 in the next twelve months. This suggests a possible upside of 132.5% from the stock's current price. View analysts price targets for VKTX or view top-rated stocks among Wall Street analysts.

Century Aluminum Co. () Stock Market info Recommendations: Buy or sell Century Aluminum stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Century Aluminum share forecasts, stock quote and buy / sell signals below.According to present data Century Aluminum's CENX shares and potentially its …

12 analysts have issued twelve-month price objectives for CymaBay Therapeutics' stock. Their CBAY share price targets range from $12.00 to $34.00. On average, they anticipate the company's stock price to reach $22.27 in the next year. This suggests a possible upside of 24.4% from the stock's current price. View analysts price targets for CBAY ...Hudbay Minerals Inc. () Stock Market info Recommendations: Buy or sell Hudbay Minerals stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Hudbay Minerals share forecasts, stock quote and buy / sell signals below.According to present data Hudbay Minerals's HBM shares and potentially its …Atreca Inc [BCEL] stock prices are down -14.82% to $0.28 at the moment. ... An investor can expect a potential return of 1060.71% based on the average BCEL price forecast. Analyzing the BCEL fundamentals. In this publicly-traded organization, revenue per employee is $8,556, ...BCEL reported Q4'22 and full year earnings on March 29. Cash, cash equivalents and investments were $70.5M at the end of 2022. R&D expenses were $66.8M for 2022 and G&A expenses were $31.5M for ...Nov 30, 2023 · Atreca, Inc. (BCEL.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Atreca, Inc. | Nasdaq: BCEL | Nasdaq The shares of micro-cap biotech, Atreca (BCEL +46.1%) have added more than a third in morning hours on Friday after the company updated early-stage data for its lead cancer candidate ATRC-101 with ...The current average BCEL price target, as estimated by these analysts, is $4.00. The predictions for the future BCEL stock price range from a low of $4.00 to a high of $4.00, highlighting the variability of market expectations for BCEL. The Atreca stock forecast for tomorrow is $ 0.213730, which would represent a -4.16% loss compared to the current price. In the next week, the price of BCEL is expected to decrease by -24.67% and hit $ 0.167988. As far as the long-term Atreca stock forecast is concerned, here’s what our ...Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...Based on 10 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $24.40 with a high forecast of $33.00 and a low forecast of $20.00. The average price target represents a 29.93% change from the last price of $18.78. Highest Price Target $33.00. Average Price Target $24.40.

msn.com - August 11 at 5:24 PM. Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring. finance.yahoo.com - August 11 at 12:47 AM. Atreca Inc - (BCEL) Price Target Increased by 11.89% to 10.20. msn.com - August 2 at 12:44 PM. Atreca Approaches A Major Go/No-Go Decision.

Find real-time BCE - BCE Inc stock quotes, company profile, news and forecasts from CNN Business.

Find the latest Patterson-UTI Energy, Inc. (PTEN) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock Price Forecast. The 20 analysts offering 12-month price forecasts for Kroger Co have a median target of 51.75, with a high estimate of 65.00 and a low estimate of 37.00. The median estimate ...Atreca, Inc.’s BCEL shares plunged about 37% on Aug 11, 2023, after the company reported structural changes in its business in the second-quarter earnings release, which failed to meet investors ...Based on short-term price targets offered by four analysts, the average price target for Atreca, Inc. comes to $5.25. The forecasts range from a low of $1.00 to a high of $10.00. The average price ...Find real-time BCE - BCE Inc stock quotes, company profile, news and forecasts from CNN Business.Nov 6, 2023 · Atreca is forecast to grow earnings and revenue by 10.3% and 9.5% per annum respectively while EPS is expected to grow by 30.2% per annum. Find the latest Morphic Holding, Inc. (MORF) stock quote, history, news and other vital information to help you with your stock trading and investing.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Viking Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Viking Therapeutics's VKTX shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).Atreca, Inc. : Forcasts, revenue, earnings, analysts expectations, ratios for Atreca, Inc. Stock | BCEL | US04965G1094Wall Street Stock Market & Finance report, prediction for the future: You'll find the Viking Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Viking Therapeutics's VKTX shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).FIXX Stock 12 Months Forecast. Based on 1 Wall Street analysts offering 12 month price targets for Homology Medicines in the last 3 months. The average price target is $1.50 with a high forecast of $1.50 and a low forecast of $1.50. The average price target represents a 167.81% change from the last price of $0.56.

Competitors. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Ideanomics Inc have a median target of 30,387.50, with a high estimate of 30,387.50 and a low estimate of ...The current Cheniere Energy [ LNG] share price is $179.21. The Score for LNG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. LNG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.The Wall Street analysts predict Outperform for BCEL. See at a glance whether NasdaqGS:BCEL will rise in the future. Company; Stock analysis; Earnings Calendars ... 4 years of reliable Atreca stock forecast. The Wall Street analysts predict Outperform for BCEL. See at a glance whether NasdaqGS:BCEL will rise in the future. …Instagram:https://instagram. ladder t billsvaluable us quarterstrading futures platformbest individual health insurance plans in georgia Earnings Summary. For their last quarter, Atreca (BCEL) reported earnings of -$0.49 per share, beating the Zacks Consensus Estimate of $-0.56 per share. This reflects a positive earnings surprise ... cash secured put vs covered callgame company stock Nov 6, 2023 · Atreca is forecast to grow earnings and revenue by 10.3% and 9.5% per annum respectively while EPS is expected to grow by 30.2% per annum. mgk etf price Wall Street Stock Market & Finance report, prediction for the future: You'll find the Century Aluminum share forecasts, stock quote and buy / sell signals below. According to present data Century Aluminum's CENX shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). The current Atreca [ BCEL] share price is $0.21. The Score for BCEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. BCEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.